PROSTACYCLIN: HAEMODYNAMIC AND METABOLIC EFFECTS IN PATIENTS WITH CORONARY ARTERY DISEASE

This publication has 13 references indexed in Scilit:

• Haemodynamic changes induced by prostacyclin in man.
  Heart, 1980
• Myocardial lactate extraction: multi-determined metabolic function.
  Circulation, 1980
• SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLIN
  The Lancet, 1979
• Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation
  Prostaglandins, 1979
• Prostacyclin is a circulating hormone
  Nature, 1978
• COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6‐OXO‐PROSTAGLANDIN F_1α WITH THOSE OF PROSTAGLANDIN E₂ IN RATS AND RABBITS
  British Journal of Pharmacology, 1978
• The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbits
  Prostaglandins, 1977
• Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium
  Thrombosis Research, 1977
• Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
  Prostaglandins, 1977
• A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
  Prostaglandins, 1976